SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors discuss the potential impact of a new CEO with big pharma experience, viewing it as a possible catalyst for a strategic partnership or buyout. Bullish sentiment is fueled by the belief that the company is undervalued and poised for significant growth in the liver disease and cardiometabolic space. Community members are actively debating the implications of this leadership transition on the company's future.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community discusses the potential impact of newly launched Dogecoin ETFs and anticipates institutional investment. While some traders express frustration with recent price action, others believe Dogecoin is establishing its own identity independent of Bitcoin's movements. Bullish sentiment remains among some, who forecast significant price increases and highlight the potential for long-term growth.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros is trending due to the closing of its asset purchase and licensing agreement with Novo Nordisk, sparking community excitement and speculation about future catalysts. Community members are also discussing the potential for FDA approval of Narsoplimab, with varied estimates of buyout prices and the impact of approval or rejection. The deal provides Omeros with significant upfront payments and potential milestones, as well as tiered royalties on net sales.

Synopsys, Inc. engages in the provision of electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). It also offers semiconductor intellectual property (IP) products. It operates through the following segments: Design Automation, Design IP, and Software Integrity. The Design Automation segment includes silicon design, verification products and services, system integration products and services, digital, custom, and FPGA IC design software, verification software and hardware products, and manufacturing software products. The Software Integrity segment includes a solution for building security and compliance testing into the customers' software development lifecycle and supply chain. The company was founded by Aart J. de Geus, Bill Krieger, Dave Gregory, and Rick Rudell in December 1986 and is headquartered in Sunnyvale, CA.

Synopsys, Inc.

Synopsys is trending following NVIDIA's $2 billion investment in the company, sparking excitement about their expanded partnership to revolutionize chip and system design with AI and accelerated computing. Community members are discussing the potential for faster simulations, smarter digital twins, and AI-driven engineering workflows. Some see this as a bullish sign for SNPS, while others are watching key support levels and Q4 earnings for further direction.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed ($WOLF) is trending due to receiving a significant $698.6 million cash tax refund from the IRS, sparking optimism about the company's financial health. Community members are discussing CNN's interesting forecast and Citigroup's updated rating with a neutral target price, while some investors see a potential short squeeze given the high short interest. Discussions also revolve around the post-restructuring financials and accounting, with many believing the current valuation is unrealistically low relative to its market position.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending amid volatile cryptocurrency markets and fluctuating Bitcoin prices, sparking intense debate about the company's future and its Bitcoin holdings. Community discussions revolve around whether MSTR will be forced to sell its Bitcoin and the potential implications of Saylor's leveraged strategy, particularly given concerns of a possible liquidity crunch. Some traders are taking bearish stances, while others remain bullish, citing potential for a short squeeze.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing volatility, with community discussions focusing on a recent price drop and potential contributing factors like Japanese monetary policy and liquidations. Some traders speculate on oversold conditions and future rallies, while others express concerns about market manipulation and a potential shift away from crypto assets. Debate continues around Bitcoin's role as a store of value versus a risk asset.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as traders anticipate upcoming earnings and the potential impact of Michael Burry's hinted insights into the stock's story, fueling speculation about a possible resurgence. Community discussions revolve around the company's cash reserves, debt-free status, and the potential for a short squeeze, while some express concerns about past dilutions and current leadership. Overall, there is a mix of bullish sentiment and skepticism as investors weigh the potential for future growth.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is trending amidst broader market uncertainty, with community members debating whether to buy the dip or exit their positions. Some traders are expressing frustration with the meme coin's performance, while others are looking for signs of a potential recovery or accumulating more, hoping for a significant rally. The conversation also includes comparisons to other meme coins and speculation about future price movements.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending amid a Bitcoin price correction, with discussions focused on whether this dip presents a buying opportunity or signals a longer-term downturn. Community members are debating potential support levels and analyzing whale activity, as well as considering the broader implications of BlackRock's ETF flows on market sentiment. Talk surrounds Microstrategy's exposure and influence, alongside commentary regarding market manipulation.

statis crypto Watchlist

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

American Bio Medica Corp. is a biotechnology company, which engages in the manufacture and sale of immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids. The firm's products include Rapid Drug Screen, Rapid ONE, RDS InCup, Rapid TOX, Rapid TOX Cup II, and OralStat. Its products are related to urinalysis, oral fluids, alcohol testing, hair testing, pregnancy testing, and lab partners. The company was founded by Stan Cipkowski and Edmund M. Jaskiewicz on April 2, 1986 and is headquartered in Kinderhook, NY.

American Bio Medica Corp.

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Current Price	N/A
Prev Close	$0.0001
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	$0.00
Beta	-79.93
Avg. Volume	1,680.75
PE Ratio	N/A

52-Week High	$0.0002
52-Week Low	$0.00
Market Capitalization	$48.00
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

ABMC
American Bio Medica Corp.

Feed

News

Sentiment

Fundamentals

Info

Latest ABMC News

ABMCAmerican Bio Medica Corp.